Skip to Content
German
English

10.50% p.a. JB Multi Barrier Reverse Convertible (70% European) with Lock-In on Eli Lilly & Co, Roche Holding AG, Novo Nordisk A/S

  • Valor 132871800
  • ISIN CH1328718007
  • Symbol MCAGJB
  • SVSP Category Yield enhancement
  • SVSP Type Barrier Reverse Convertibles
  • SVSP Code 1230

Bid

%

Volume:

Ask

%

Volume:

Price

as of:
Distance to strike (%) -57.05%
Distance to barrier -9.94%
Delta LLY=0.152,​NVO=0.632,​ROG=0.034
multiple Underlyings Yes
days to maturity 250
Summary Risk Indicator (SRI)*
1 2 3 4 5 6 7

*All statements without guarantee.

JB ESG Category Responsible Investments
SFDR Alignment (JB View) No
EU Taxonomy Aligned No
% of EU Taxonomy Alignment 0.00%
Daily high (bid) 78.75
Daily low (bid) 73.80
52 Week high (bid) 98.60
52 Week low (bid) 73.80
Alltime high (bid) 98.60
Alltime low (bid) 73.80
Worst performing underlying Novo Nordisk
Performance of the underlying since issue -36.33%
Initial fixing date 20/09/2024
Issue date 27/09/2024
Next coupon payment 27/01/2025
Maturity date 22/09/2025
Callability No
Issuer Bank Julius Baer & Co. Ltd., Guernsey
Underlying Eli Lilly & Co
Novo Nordisk
Roche Holding Ltd
Issue price 100.00
Currency USD
Listing Yes
COSI No
Coupon p.a. 10.50%
Strike 100%
Barrier (%) 70.00%
Barrier observation continuous
Quanto Yes
Trigger Barrier 105.00%
Trigger Step-Down No
Payment Scenario Barrier Reverse Convertibles
market expectation
characteristics
  • Underlying moving sideways or slightly rising
  • Falling volatility
  • Underlying will not breach barrierduring product lifetime
  • Should the barrier never be breached, the nominal plus coupon is paid at redemption
  • Due to the barrier, the probability of maximum redemption is higher; the coupon, however, is smaller than for a Reverse Convertible
  • If the barrier is breached the product changes into a Reverse Convertible
  • The coupon is paid regardless of the underlying development
  • Reduced risk compared to a direct investment into the underlying
  • With higher risk levels, multiple underlyings (“Worst-of”) allow for higher coupons or lower barriers
  • Limited profit opportunity(cap)

Eli Lilly & Co

  • Ticker SymbolLLY UN
  • Valor947556
  • ISINUS5324571083

746.44 USD

Novo Nordisk

  • Ticker SymbolNVO UN
  • Valor461641
  • ISINUS6701002056

81.48 USD

Roche Holding Ltd

  • Ticker SymbolROG SW
  • Valor1203204
  • ISINCH0012032048

263.40 CHF

Back to top